1. Home
  2. AZTA vs ORIC Comparison

AZTA vs ORIC Comparison

Compare AZTA & ORIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Azenta Inc.

AZTA

Azenta Inc.

SELL

Current Price

$40.15

Market Cap

1.5B

Sector

Technology

ML Signal

SELL

Logo Oric Pharmaceuticals Inc.

ORIC

Oric Pharmaceuticals Inc.

BUY

Current Price

$11.76

Market Cap

1.4B

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
AZTA
ORIC
Founded
1978
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.4B
IPO Year
1996
2020

Fundamental Metrics

Financial Performance
Metric
AZTA
ORIC
Price
$40.15
$11.76
Analyst Decision
Buy
Strong Buy
Analyst Count
6
16
Target Price
★ $37.00
$21.43
AVG Volume (30 Days)
828.3K
★ 1.4M
Earning Date
11-20-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 19.67
EPS
N/A
★ N/A
Revenue
★ $593,821,000.00
N/A
Revenue This Year
$3.59
N/A
Revenue Next Year
$4.29
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$15.93
$7.23
52 Week High
$46.41
$14.68

Technical Indicators

Market Signals
Indicator
AZTA
ORIC
Relative Strength Index (RSI) 69.14 36.84
Support Level $32.40 $10.17
Resistance Level $41.73 $12.59
Average True Range (ATR) 1.63 0.75
MACD 0.70 -0.11
Stochastic Oscillator 52.12 9.02

Price Performance

Historical Comparison
AZTA
ORIC

About AZTA Azenta Inc.

Azenta Inc provides biological and chemical sample exploration and management solutions, using precision automation and cryogenics to develop automated ultra-cold storage. It serves customers from research to commercialization with sample management, automated storage, genomic services, consumables, informatics, and repository services. The company operates through two segments: Sample Management Solutions, offering SRS and Core Products such as automated stores, cryogenic systems, sample tubes, consumables, instruments, and thawing devices, which generate majority of its revenue; and Multiomics, which provides genomic analysis services. The company operates in United States, China, United Kingdom, rest of Europe, and others, with majority of its revenue in the United States.

About ORIC Oric Pharmaceuticals Inc.

ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.

Share on Social Networks: